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2Abstract
Many MRI techniques require prior knowledge of the T1-relaxation time of blood (T1bl). An
assumed/fixed value is often used, however, T1bl is sensitive to magnetic field (B0),
haematocrit (Hct), and oxygen saturation (Y). We aimed to combine data from previous in
vitro measurements into a mathematical model, to estimate T1bl as a function of B0, Hct, and
Y. The model was shown to predict T1bl from in vivo studies with a good accuracy (±87ms).
This model allows for improved estimation of T1bl between 1.5-7.0T while accounting for
variations in Hct and Y, leading to improved accuracy of MRI-derived perfusion
measurements.
Keywords: ASL, Cerebral blood flow measurement, MRI, Perfusion weighted MRI,
Mathematical modelling
3Introduction
The spin-lattice relaxation time of blood (T1bl) plays a critical role in a range of MRI
applications. In particular, the accuracy of blood flow measurements made using arterial spin
labelling (ASL)1 depends directly on accurate knowledge of T1bl in a given subject. Black
blood angiography, vascular space occupancy imaging, dynamic contrast-enhanced
magnetic resonance imaging, cardiac MRI applications and MR-based temperature
monitoring also rely on accurate estimation of this parameter.
A number of factors influence spin-lattice relaxation time (T1). T1 increases with Larmor
frequency, and therefore magnetic field strength (B0), which in single phase homogeneous
substances can be described using the Bloembergen-Purcell-Pound theory2. In human
tissues and blood, the relationship is more complex, as macromolecules such as proteins
provide relaxation pathways which speed up T1 relaxation. One such protein is haemoglobin,
which is an oxygen transport protein that resides in erythrocytes (red blood cells), and hence
haematocrit (Hct), which describes the volume fraction of erythrocytes in whole blood, will
influence T1bl. Proteins residing in blood plasma, such as albumin and globulin, will similarly
effect T1bl. In addition, paramagnetic materials provide a further T1 relaxation pathway, and,
as deoxyhaemoglobin is weakly paramagnetic, the oxygen saturation fraction of blood (Y)
will also influence T1 relaxation. Lastly, the T1 relaxation time is temperature-dependent, with
longer relaxation times found at higher temperatures.
In general, an assumed value of T1bl will be used in the MRI techniques described above,
particularly in the clinic, where technical and scan time constraints prevent measurement of
T1bl on a patient-by-patient basis. Although many previous studies have determined values
of T1bl empirically (see Table 1), these have generally been performed under differing
physiological / experimental conditions (magnetic field strength, blood oxygenation,
haematocrit, etc), often without direct measurement of all the influencing factors. The aim of
this study was to bring together the results of previous studies into a general mathematical
model for predicting T1bl, as a function of B0, Hct, and Y. This will provide estimates of T1bl
values in arterial and venous blood, over the range of magnetic field strengths used in
clinical practice (1.5-7.0 T). This should lead to subsequent improvements in the accuracy of
ASL-derived blood flow measurements, particularly in pathologies where the constitution of
the blood is known to be outside the normal range.
Materials and Methods
4Theory
A two compartment blood model, consisting of erythrocytes and plasma in fast exchange,
was previously described in 3. In this model, the longitudinal relaxation rate of whole blood
(R1bl, equivalent to T1bl-1), is given by:
ܴଵ௕௟(ܪ ܿݐ,ܻ) = ௘݂ ∙ ܴଵ௘(ܻ) + (1 − ௘݂) ∙ ܴଵ௣ [1]
where Hct is the haematocrit (0 to 1), Y is the oxygen saturation fraction (0 to 1), fe is the
fraction of water in whole blood that resides in erythrocytes (0 to 1), R1e is the longitudinal
relaxation rate of erythrocytes (s-1), and R1p is the longitudinal relaxation rate of plasma (s-1).
Under normal physiological conditions, water volume fraction in erythrocytes is
approximately 70%, and water volume fraction in plasma is 94-95%3, which allows fe to be
expressed as a function of Hct as follows 3:
௘݂ = 0.70 ∙ ܪ ܿݐ0.70 ∙ ܪ ܿݐ+ 0.95 ∙ (1 − ܪ ܿݐ) [2]
In addition, because deoxyhaemoglobin acts as a weak paramagnetic contrast agent, we
can express R1e as a function of Y:
ܴଵ௘(ܻ) = ܴଵ௘௢௫ + ݎଵௗ௘௢௫௬ு௕ ∙ [ܪ ]ܾ ∙ (1 − ܻ) [3]
where R1eox is the longitudinal relaxation rate of erythrocytes when Y=1 (100% oxygen
saturation), [Hb] is the mean corpuscular haemoglobin concentration (5.15 mmol Hb
tetramer / L plasma3), and r1deoxyHb is the molar relaxivity of deoxyhaemoglobin (s-1 L plasma
in erythrocyte / mmol Hb tetramer).
When analysing data collected over a range of magnetic field strengths, the possible
dependence of R1eox, R1p and r1deoxyHb on B0 must also be accounted for. The relationship
between whole blood R1 and B0 between 1.5-7.0 T has been shown to be linear4, and as
such linear regression terms for the above parameters were substituted into equations [1]
and [3] as follows (β0 represents the ‘intercept’ term, β1 represents the ‘gradient’ with respect
to B0):
ܴଵ௘௢௫ = ߚ଴,ோଵ௘௢௫ + ߚଵ,ோଵ௘௢௫ ∙ ܤ଴ [4]
ݎଵௗ௘௢௫௬ு௕ = ߚ଴,௥ଵௗ௘௢௫௬ு௕ + ߚଵ,௥ଵௗ௘௢௫௬ு௕ ∙ ܤ଴
ܴଵ௣ = ߚ଴,ோଵ௣ + ߚଵ,ோଵ௣ ∙ ܤ଴ [5][6]
5By combining equations [1-6], a general model was constructed, with R1bl as the dependent
variable, B0, Hct and Y as independent variables, and the following as fitted parameters:
β0,R1eox, β1,R1eox, β0,r1deoxyHb, β1,r1deoxyHb, β0,R1p, β1,R1p.
Data analysis
All data analysis was performed using Matlab R2014a (MathWorks Inc., Natick, MA), and
Matlab’s fminsearch algorithm was used for model fitting. 42 literature values of T1bl3,5–8,
acquired in vitro between 1.5-7.0 T in conjunction with empirically controlled variations in Hct
and Y (see Table 1), were fit simultaneously to the model. The T1bl values in 6 were
increased by 12% to account for the shift in T1bl between 22°C and 37°C5,6. Following initial
model fitting, a Monte Carlo simulation was performed to determine the uncertainty on the
fitted parameters. Here, the pool of N=42 raw data points were randomly sampled N times
(with replacement), and the model was fit to this synthetic raw data set. This process was
iterated 1000 times, and the median and 95% confidence interval (CI) of the distribution of
fitted values for each parameter were used as the final parameter estimate and its
uncertainty, respectively. Parameters for which the 95% CI crossed zero were classified as
non-significant, and the process was repeated with these terms set to zero.
Following this, the fitted parameter values were substituted into equations 1-6, and the ability
of the model to predict values of T1bl taken from further literature sources4,9–11 (Table 1), in
which measurements were made in vivo, was tested. These comprised 48 values of T1bl,
taken from human studies performed between 1.5-7.0 T. In these studies measurements
were made in blood in the sagittal sinus, so normal values of Y=0.68 (for venous blood) were
assumed12, and, where not measured, a value of Hct, corrected for age and gender, was
estimated based on13,14.
Results
The Monte Carlo simulation showed that the 95% CI around the fitted value of β1,r1deoxyHb
crossed zero, and as such this parameter was non-significant (i.e. there was no evidence to
suggest r1deoxyHb changes with B0). With this term set to zero, the following values were
obtained for the remaining fitted parameters (95% lower and upper CIs shown in brackets):
β0,R1eox: 1.10 (0.97, 1.28) s-1, β1,R1eox: -0.058 (-0.085, -0.038) s-1T-1, β0,r1deoxyHb: 0.033 (1.8x10-9,
0.056) s-1 L plasma in erythrocyte / mmol Hb tetramer, and β0,R1p: 0.49 (0.40, 0.57) s-1, β1,R1p:
-0.023 (-0.035, -0.0079) s-1 T-1.
6With the above values substituted into equations 1-6, the difference between predicted and
measured T1bl values (ΔT1bl), taken from the in vivo literature sources4,9,10, is illustrated in
Figure 1a. Predicted T1bl values were slightly under-estimated compared to in vivo literature
values, with a mean ΔT1bl of -108ms (predicted-literature values, mean 6% under-
estimation), and a standard deviation in ΔT1bl of 89ms. As such, an offset of +108ms should
be added to the model when predicting in vivo T1b values (see Discussion). The final model,
valid between 1.5-7.0 T, is therefore:
ܴଵ௕௟′(ܪ ܿݐ,ܻ,ܤ଴)= ൬ 0.70 ∙ ܪ ܿݐ
0.70 ∙ ܪ ܿݐ+ 0.95 ∙ (1 − ܪ ܿݐ)൰
∙ 1ൣ.099 − (0.057 ∙ ܤ଴) + ൫(0.033 ∙ [ܪ ]ܾ) ∙ (1 − ܻ)൯൧+ ൤൬1 − ൤ 0.70 ∙ ܪ ܿݐ
0.70 ∙ ܪ ܿݐ+ 0.95 ∙ (1 − ܪ ܿݐ)൨൰∙ (0.496 − 0.023 ∙ ܤ଴)൨
[7]
ଵܶ௕௟(ܪ ܿݐ, ,ܻܤ଴) = 1ܴଵ௕௟′(ܪ ܿݐ, ,ܻܤ଴) + Δ ଵܶ௕௟
where ΔT1bl = 0 and 108 ms for in vitro and in vivo studies respectively. Note if a full
blood analysis has been performed, a measured value for [Hb] (mean corpuscular
haemoglobin concentration) can be used in equation 7, rather than the assumed value
of 5.15 mmol Hb tetramer / L plasma.
[8]
Figure 1b illustrates the change in both modelled and measured in vivo T1bl values as a
function of Hct, shown here at 3.0 T.
Discussion
After correcting for the ΔT1bl offset, our model was able to predict literature measurements of
in vivo T1bl with a good degree of accuracy (root mean square error = 87ms). For example, in
4 the measured T1bl values in venous blood in the sagittal sinus of healthy subjects (mean
age 31 years) at 1.5 T, 3.0 T, and 7.0 T were 1480ms, 1650ms and 2088ms respectively
(males and females combined). The equivalent values predicted using our model were
1565ms, 1688ms, and 2147ms respectively (data in 4 were not used to ‘train’ the model).
Our model fitting indicated that both the T1 of plasma and fully-oxygenated erythrocytes
increase with B0, and our results agree with previous findings that T1bl is highly sensitive to
haematocrit, but only weakly dependent on oxygenation15. Also, our fitted value for r1deoxyHb of
0.033 s-1 L plasma in erythrocyte/mmol Hb tetramer lies between the mean fitted values of
0.052 in 3 and 0.012 in 15 (s-1 L plasma in erythrocyte / mmol Hb tetramer). It should be
7noted that if a full blood analysis shows mean corpuscular haemoglobin concentration to be
significantly different from the assumed value used in this study, the validity of the model
could be slightly impaired.
The offset between predicted and literature T1bl values arose from the fact that our model
was ‘trained’ using data from in vitro studies (necessary to control the Hct and Y levels in the
blood), then used to predict values from in vivo studies. Trisodium citrate was added to the
blood in the in vitro studies to prevent coagulation, and higher osmolarity sodium
concentrations will draw water out of erythrocytes via osmosis, shortening T13. In 3, the
addition of anti-coagulant was estimated to reduce T1bl by 7%, which agrees very well with
the average under-estimation of 6% when our model was used to predict literature values
acquired in vivo.
Implications for Arterial Spin Labelling
When processing ASL data, an assumed value of T1bl is used in the conversion of raw signal
into cerebral blood flow (CBF) values (see 16 for details). Certain pathologies may result in a
patient having a haematocrit outside the normal range expected for their age/gender, and
assuming a normal Hct value in these patients will result in an incorrect estimation of T1bl,
which in turn will lead to an incorrect calculation of CBF. For instance, sickle cell anaemia is
a genetic condition in which patients have atypical haemoglobin molecules, resulting in a low
number of red blood cells (anaemia). In a severely anaemic patient (say Hct=0.20), the
calculated value of T1bl in arterial blood (Y=0.97) using our model would be 2.09 s at 3.0 T. If
we assumed a normal Hct value in this subject, (say Hct=0.47 for a 30 year old male), the
calculated value of T1bl drops to 1.70 s. This 18% under-estimation of T1bl, resulting from an
assumed normal value for T1bl rather than a Hct-corrected value, would lead to an
overestimation in the calculated CBF of approximately 30%, based on a typical pseudo-
continuous ASL acquisition (see equation 1 in 16).
Conclusions
MRI applications such as ASL are dependent on accurate knowledge of T1bl, which is rarely
measured on a patient-by-patient basis. We have presented a mathematical model which
brings together previous empirical measurements of T1bl, and provides a general tool for
estimation of this parameter in individual subjects, adjusted for magnetic field strength,
haematocrit and oxygenation of the blood. In healthy subjects, this model can be used with
assumed normal values of Hct (corrected for age/gender) and Y, whereas in patients
measured Hct and Y values may be required, which will require blood sampling and non-
trivial steps for accurate assessment. Following this, the model presented here will account
8for the influence of a patient’s atypical Hct and Y values on the estimated value of T1bl. This
in turn will have a significant influence on the quantification of CBF using ASL, and
considerable errors in CBF quantification will occur if normal values of T1bl are assumed.
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Figure legends
Figure 1 (A) Bland-Altman plot illustrating the difference between modelled and measured
values of T1bl (ΔT1bl), between 1.5-7.0 T. The horizontal dashed lines show the mean value
of ΔT1bl (short dashes) and the limits of agreement (long dashes, mean(ΔT1bl) ±
(1.96xSD(ΔT1bl)). (B) Variation in modelled values of T1bl (black line, with grey shading
indicating limits of agreement), with literature values overlaid (legend indicates literature
source in (A) and (B)). All data in (B) represent in vivo T1bl values, and as such the ΔT1bl =
180 ms offset has been added to the modelled values (equation 8).
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Table 1 Sources of literature values of R1bl.
Ref. B0 (T) No.
data
points
Blood
source
Age
range
(years)
Gender Hct Y
Stefanovic 6 1.5 8 Human
(22 °C)
- - Measured
(0.51±
0.004)
Measured
(0.42-
0.93)
Lu 5 3.0 9 Bovine
(37 °C)
- - Measured
(0.38-
0.46)
Measured
(0.69-
0.99)
Rane 7 7.0 10 Human
(37 °C)
- - Measured
(0-1)
Measured
(0.66-
0.97)
Grgac 3 7.0 13 Bovine
(37 °C)
- - Measured
(0-1)
Measured
(0.4-1.0)
Dobre 8 4.7,7.0 2 Bovine
(37 °C)
- - Measured
(0.43)
Measured
(0.79-
0.81)
Zhang 4 1.5,
3.0,
7.0
18 Human
in-vivo
24-38 M, F Estimated Estimated
(venous)
Wu 9 3.0 8 Human
in-vivo
7-39 M, F Estimated Estimated
(venous)
Varela 10 3.0 19 Human
in-vivo
0.4-37 M, F Measured Estimated
(venous)
De Vis 11 3.0 3 Human
in-vivo
0.05-
0.24
M,F Measured Estimated
(venous)
The range of Hct and Y are shown if these parameters were measured, if not estimated
values were used, adjusted for the age and gender of the subject (for Hct), and whether the
blood was arterial or venous (for Y).
